D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002614:Chelating Agents; D003094:Collagen / Q000096:biosynthesis; D003300:Copper / Q000378:metabolism; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D009404:Nephrotic Syndrome / Q000139:chemically induced; D010396:Penicillamine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D012594:Scleroderma, Localized / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D012871:Skin Diseases / Q000139:chemically induced; D013651:Taste Disorders / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D002614:Chelating Agents; D003300:Copper; D003094:Collagen; D010396:Penicillamine